Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Entero Therapeutics (ENTO) has provided an announcement.
Entero Therapeutics, Inc. has announced through a press release by CEO James Sapirstein a letter to its shareholders. The communication, which is not considered filed under SEC regulations, provides updates without becoming part of the company’s formal SEC filings. This move aims to keep shareholders informed without adding to the company’s legal filings.
See more insights into ENTO stock on TipRanks’ Stock Analysis page.